HIT: Multiplikator Forward P/S healthintech.com

Health In Tech Inc. - logo grafis emiten HIT

Health In Tech Inc (HIT) automates underwriting via a fintech platform, developing software R&D for rapid quote calculation. The expected price-to-sales ratio helps assess the business's real value, where 0.90 expresses the current value of the metric. Ambitious management relies on data analysis to create efficient insurance products for small businesses.

HIT (Health In Tech) riwayat Rega forward marang dodolan saka 24.12.2024 nganti 13.11.2026

healthintech.com - rincian analitis lan metrik utama (HIT)

- rega saham lan target rega konsensus:
Ringkesan analisis perusahaan:Health In Tech, Inc. (HIT)
Produk asli Health In Tech Inc.

To minimize investment risks, it is essential to assess the resilience of Health In Tech Inc. (HIT) capitalization against reductions in government subsidies and tax changes. Analyzing the Insurtech platform's ability to monetize medical plan administration through forward price-to-sales (P/S) ratio dynamics allows for the determination of the business's margin of safety. This indicator compares market value with expected revenues, identifying whether the asset is overbought or possesses growth potential when adapting to new fiscal conditions.